Sunshine Data Could Fast-Track False Claims Act Cases – U.S. Prosecutors
Sunshine Act penalties are relatively small but the payment disclosures could provide ammo and shortcuts for investigations into the more costly False Claims Act cases, U.S. attorneys say. On the flip side, disclosure may lead to better behavior.
You may also be interested in...
AstraZeneca, Merck, Novartis and Sanofi are also under investigation for potential health care fraud.
HHS Office of Inspector General’s Mary Riordan advises drug makers to analyze their speaker programs and consulting arrangements for possible kickback activities.
FDA advisors will vote 28 June on whether an Omicron component should be included in new COVID-19 booster vaccines. Following WHO recommendations, the FDA may no longer also be looking to update the primary vaccine series at this time.